TPG, a US private equity investment firm, has completed an acquisition of Optum UK, the healthcare technology company that manages the electronic patient record system relied upon by the majority of general practices across England. The transaction, valued at approximately $400m (£300m), grants TPG control over infrastructure handling patient records for millions of NHS patients.
The acquisition has generated significant criticism from medical professionals, campaigners, members of parliament, and human rights organizations, who contend that the deal proceeded with insufficient public transparency and oversight. Representatives from Doctors’ Association UK emphasized concern that control of general practice infrastructure now rests with a private equity firm prioritizing investor returns rather than patient care. Helen Morgan, the Liberal Democrats’ health spokesperson, characterized such arrangements as being approved without adequate scrutiny or patient protections, and urged the government to prioritize British technology companies instead.
Opposition to the deal has been amplified by TPG’s international healthcare operations. An investigation conducted earlier this year by the International Consortium of Investigative Journalists examined hospitals in Kenya owned by Evercare, a healthcare entity backed by TPG’s Rise Fund. The investigation documented allegations that certain patients accumulated substantial debts and in some instances were required to pledge land deeds as security for unpaid medical expenses. TPG disputed these characterizations, stating it has invested more than $100m across Evercare over six years, resulting in quality and accessibility improvements alongside patient protections.
EMIS, acquired as part of the Optum UK transaction, provides software to more than half of English GP practices, positioning it as a critical NHS primary care technology provider. EMIS and TPG representatives asserted that the ownership change does not alter data protection mechanisms or legal safeguards. EMIS stated the acquisition underwent government review under the National Security and Investment Act 2021. Anna Marriott, former Oxfam health policy lead, cautioned that private equity’s expansion within the health service is outpacing regulatory frameworks designed to protect patients and the public interest.
Article Attribution | Read More at Article Source
Article summary produced by Claude AI